Treating latent tuberculosis infection (LTBI) with isoniazid and rifapentine (3HP) in an inner-city population with psychosocial barriers to treatment adherence: A qualitative descriptive study.

In Canada, preventive therapy for latent tuberculosis infection (LTBI) has required multiple doses of medication over an extended period of time. Such regimens are associated with poor adherence and completion rates. A shortened treatment regimen of once weekly isoniazid plus rifapentine for 3 month...

Full description

Bibliographic Details
Published in:PLOS Global Public Health
Main Authors: Amber Heyd, Courtney Heffernan, Kate Storey, T Cameron Wild, Richard Long
Format: Article in Journal/Newspaper
Language:English
Published: Public Library of Science (PLoS) 2021
Subjects:
Online Access:https://doi.org/10.1371/journal.pgph.0000017
https://doaj.org/article/dcaeea80fcf04f648fa2b9b81f06a0d4
id ftdoajarticles:oai:doaj.org/article:dcaeea80fcf04f648fa2b9b81f06a0d4
record_format openpolar
spelling ftdoajarticles:oai:doaj.org/article:dcaeea80fcf04f648fa2b9b81f06a0d4 2023-10-09T21:51:36+02:00 Treating latent tuberculosis infection (LTBI) with isoniazid and rifapentine (3HP) in an inner-city population with psychosocial barriers to treatment adherence: A qualitative descriptive study. Amber Heyd Courtney Heffernan Kate Storey T Cameron Wild Richard Long 2021-01-01T00:00:00Z https://doi.org/10.1371/journal.pgph.0000017 https://doaj.org/article/dcaeea80fcf04f648fa2b9b81f06a0d4 EN eng Public Library of Science (PLoS) https://doi.org/10.1371/journal.pgph.0000017 https://doaj.org/toc/2767-3375 2767-3375 doi:10.1371/journal.pgph.0000017 https://doaj.org/article/dcaeea80fcf04f648fa2b9b81f06a0d4 PLOS Global Public Health, Vol 1, Iss 12, p e0000017 (2021) Public aspects of medicine RA1-1270 article 2021 ftdoajarticles https://doi.org/10.1371/journal.pgph.0000017 2023-09-10T00:40:36Z In Canada, preventive therapy for latent tuberculosis infection (LTBI) has required multiple doses of medication over an extended period of time. Such regimens are associated with poor adherence and completion rates. A shortened treatment regimen of once weekly isoniazid plus rifapentine for 3 months (3HP), is now available, and holds promise in populations facing challenges to treatment adherence. Although many factors impact treatment adherence, a knowledge gap exists in describing these factors in the context of this regimen. We present findings from a qualitative descriptive study, involving semi-structured interviews with unstably housed or homeless individuals in Edmonton and Fort McMurray, Alberta, Canada who were offered directly-observed preventive therapy (DOPT) with 3HP, and their health care providers. Latent content analysis revealed incomplete understandings of LTBI and about the need for preventive therapy. Clients' motivation to be healthy, alongside education, health care outreach, relationships developed in the context of DOPT, ease of treatment regimen, incentives, and collaboration were all described as supporting treatment completion. Competing priorities, difficulty in reaching clients, undesirable aspects of the regimen and difficulties obtaining and initiating 3HP were identified as barriers. Perceptions of stigma related to LTBI and TB were described by clients in addition to feelings of shame related to their diagnosis. Our study provides insight into LTBI and indicates that multiple interacting psychosocial factors influence preventive therapy access, uptake, and adherence. Findings from this study of both client and provider perspectives can be used to inform and address inequities among individuals experiencing homelessness, and ultimately contribute to a diminished reservoir of LTBI. Article in Journal/Newspaper Fort McMurray Directory of Open Access Journals: DOAJ Articles Canada Fort McMurray PLOS Global Public Health 1 12 e0000017
institution Open Polar
collection Directory of Open Access Journals: DOAJ Articles
op_collection_id ftdoajarticles
language English
topic Public aspects of medicine
RA1-1270
spellingShingle Public aspects of medicine
RA1-1270
Amber Heyd
Courtney Heffernan
Kate Storey
T Cameron Wild
Richard Long
Treating latent tuberculosis infection (LTBI) with isoniazid and rifapentine (3HP) in an inner-city population with psychosocial barriers to treatment adherence: A qualitative descriptive study.
topic_facet Public aspects of medicine
RA1-1270
description In Canada, preventive therapy for latent tuberculosis infection (LTBI) has required multiple doses of medication over an extended period of time. Such regimens are associated with poor adherence and completion rates. A shortened treatment regimen of once weekly isoniazid plus rifapentine for 3 months (3HP), is now available, and holds promise in populations facing challenges to treatment adherence. Although many factors impact treatment adherence, a knowledge gap exists in describing these factors in the context of this regimen. We present findings from a qualitative descriptive study, involving semi-structured interviews with unstably housed or homeless individuals in Edmonton and Fort McMurray, Alberta, Canada who were offered directly-observed preventive therapy (DOPT) with 3HP, and their health care providers. Latent content analysis revealed incomplete understandings of LTBI and about the need for preventive therapy. Clients' motivation to be healthy, alongside education, health care outreach, relationships developed in the context of DOPT, ease of treatment regimen, incentives, and collaboration were all described as supporting treatment completion. Competing priorities, difficulty in reaching clients, undesirable aspects of the regimen and difficulties obtaining and initiating 3HP were identified as barriers. Perceptions of stigma related to LTBI and TB were described by clients in addition to feelings of shame related to their diagnosis. Our study provides insight into LTBI and indicates that multiple interacting psychosocial factors influence preventive therapy access, uptake, and adherence. Findings from this study of both client and provider perspectives can be used to inform and address inequities among individuals experiencing homelessness, and ultimately contribute to a diminished reservoir of LTBI.
format Article in Journal/Newspaper
author Amber Heyd
Courtney Heffernan
Kate Storey
T Cameron Wild
Richard Long
author_facet Amber Heyd
Courtney Heffernan
Kate Storey
T Cameron Wild
Richard Long
author_sort Amber Heyd
title Treating latent tuberculosis infection (LTBI) with isoniazid and rifapentine (3HP) in an inner-city population with psychosocial barriers to treatment adherence: A qualitative descriptive study.
title_short Treating latent tuberculosis infection (LTBI) with isoniazid and rifapentine (3HP) in an inner-city population with psychosocial barriers to treatment adherence: A qualitative descriptive study.
title_full Treating latent tuberculosis infection (LTBI) with isoniazid and rifapentine (3HP) in an inner-city population with psychosocial barriers to treatment adherence: A qualitative descriptive study.
title_fullStr Treating latent tuberculosis infection (LTBI) with isoniazid and rifapentine (3HP) in an inner-city population with psychosocial barriers to treatment adherence: A qualitative descriptive study.
title_full_unstemmed Treating latent tuberculosis infection (LTBI) with isoniazid and rifapentine (3HP) in an inner-city population with psychosocial barriers to treatment adherence: A qualitative descriptive study.
title_sort treating latent tuberculosis infection (ltbi) with isoniazid and rifapentine (3hp) in an inner-city population with psychosocial barriers to treatment adherence: a qualitative descriptive study.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doi.org/10.1371/journal.pgph.0000017
https://doaj.org/article/dcaeea80fcf04f648fa2b9b81f06a0d4
geographic Canada
Fort McMurray
geographic_facet Canada
Fort McMurray
genre Fort McMurray
genre_facet Fort McMurray
op_source PLOS Global Public Health, Vol 1, Iss 12, p e0000017 (2021)
op_relation https://doi.org/10.1371/journal.pgph.0000017
https://doaj.org/toc/2767-3375
2767-3375
doi:10.1371/journal.pgph.0000017
https://doaj.org/article/dcaeea80fcf04f648fa2b9b81f06a0d4
op_doi https://doi.org/10.1371/journal.pgph.0000017
container_title PLOS Global Public Health
container_volume 1
container_issue 12
container_start_page e0000017
_version_ 1779314731293605888